<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Certain Gabapentin Immunoassay Kits and Test Strips, Components Thereof, and Methods Therefor; Notice of Commission Determination To Issue a Limited Exclusion Order Against Defaulting Respondent; Termination of the Investigation</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Certain Gabapentin Immunoassay Kits and Test Strips, Components Thereof, and Methods Therefor; Notice of Commission Determination To Issue a Limited Exclusion Order Against Defaulting Respondent; Termination of the Investigation</h1>
    <p class="timestamp">Published: 2022-07-29 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>Notice is hereby given that the U.S. International Trade Commission has determined to issue a limited exclusion order against Kappa City Biotech, SAS of Montlucon, France ("Kappa City"). The Commission has also determined to impose a bond equal to one hundred (100) percent of the entered value of the infringing products imported during the period of Presidential review. The investigation is hereby terminated.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> International Trade Commission</p>
    <p><strong>Document Number:</strong> 2022-16261</p>
    <p><strong>Publication Date:</strong> 2022-07-29</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/07/29/2022-16261/certain-gabapentin-immunoassay-kits-and-test-strips-components-thereof-and-methods-therefor-notice">https://www.federalregister.gov/documents/2022/07/29/2022-16261/certain-gabapentin-immunoassay-kits-and-test-strips-components-thereof-and-methods-therefor-notice</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-16261</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
